Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Chemcrux Enterp.
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 20.01 | 22.29 | 15.84 | 21.81 | 18.54 | 17.11 | 17.76 | 19.42 | 15.72 | 16.50 | 17.75 | 22.11 | 24.28 |
| Expenses + | 14.90 | 18.43 | 13.50 | 17.43 | 15.92 | 15.05 | 15.40 | 16.73 | 13.61 | 14.87 | 15.96 | 18.58 | 20.10 |
| Operating Profit | 5.11 | 3.86 | 2.34 | 4.38 | 2.62 | 2.06 | 2.36 | 2.69 | 2.11 | 1.63 | 1.79 | 3.53 | 4.18 |
| OPM % | 25.54% | 17.32% | 14.77% | 20.08% | 14.13% | 12.04% | 13.29% | 13.85% | 13.42% | 9.88% | 10.08% | 15.97% | 17.22% |
| Other Income + | 0.18 | 0.18 | 0.24 | 0.56 | 0.35 | 0.39 | 0.26 | 0.61 | 0.24 | 0.44 | 0.63 | 0.60 | 0.36 |
| Interest | 0.47 | 0.31 | 0.21 | 0.17 | 0.13 | 0.13 | 0.33 | 0.60 | 0.69 | 0.86 | 0.83 | 0.76 | 0.70 |
| Depreciation | 0.58 | 0.57 | 0.58 | 0.58 | 0.55 | 0.56 | 0.73 | 0.92 | 0.99 | 1.18 | 1.20 | 1.19 | 1.17 |
| Profit before tax | 4.24 | 3.16 | 1.79 | 4.19 | 2.29 | 1.76 | 1.56 | 1.78 | 0.67 | 0.03 | 0.39 | 2.18 | 2.67 |
| Tax % | 31.13% | 26.27% | 30.17% | 36.75% | 3.49% | 29.55% | 26.28% | 25.84% | 68.66% | -233.33% | 46.15% | 27.98% | 30.71% |
| Net Profit + | 2.92 | 2.33 | 1.24 | 2.66 | 2.21 | 1.24 | 1.15 | 1.32 | 0.21 | 0.09 | 0.21 | 1.58 | 1.85 |
| EPS in Rs | 1.97 | 1.57 | 0.84 | 1.80 | 1.49 | 0.84 | 0.78 | 0.89 | 0.14 | 0.06 | 0.14 | 1.07 | 1.25 |
Financials of Chemcrux Enterp.
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 95.27 | 95.15 | 78.47 | 70.01 | 80.65 |
| Expenses + | 74.56 | 73.69 | 65.10 | 60.78 | 69.50 |
| Operating Profit | 20.71 | 21.46 | 13.37 | 9.23 | 11.15 |
| OPM % | 21.74% | 22.55% | 17.04% | 13.18% | 13.83% |
| Other Income + | 1.00 | 1.05 | 1.18 | 1.49 | 2.02 |
| Interest | 0.17 | 0.82 | 0.83 | 1.75 | 3.15 |
| Depreciation | 1.59 | 2.04 | 2.29 | 3.21 | 4.73 |
| Profit before tax | 19.95 | 19.65 | 11.43 | 5.76 | 5.29 |
| Tax % | 25.51% | 26.92% | 26.16% | 32.12% | 29.30% |
| Net Profit + | 14.86 | 14.36 | 8.44 | 3.91 | 3.73 |
| EPS in Rs | 10.03 | 9.70 | 5.70 | 2.64 | 2.52 |
| Dividend Payout % | 19.93% | 20.63% | 17.55% | 37.88% | 39.71% |
Financials of Chemcrux Enterp.
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 |
| Reserves | 39.87 | 51.60 | 57.45 | 59.81 | 62.04 |
| Borrowings + | 9.75 | 14.43 | 26.46 | 42.30 | 34.37 |
| Other Liabilities + | 19.34 | 12.38 | 11.15 | 10.13 | 16.22 |
| Total Liabilities | 83.77 | 93.22 | 109.87 | 127.05 | 127.44 |
| Fixed Assets + | 25.49 | 33.11 | 33.09 | 77.06 | 74.96 |
| CWIP | 0.00 | 0.31 | 21.06 | 1.61 | 4.08 |
| Investments | 7.08 | 16.79 | 19.83 | 19.83 | 15.93 |
| Other Assets + | 51.20 | 43.01 | 35.89 | 28.55 | 32.47 |
| Total Assets | 83.77 | 93.22 | 109.87 | 127.05 | 127.44 |
Financials of Chemcrux Enterp.
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 9.16 | 14.82 | 16.34 | 7.59 | 13.85 |
| Cash from Investing Activity + | -2.64 | -20.48 | -25.89 | -2.48 | -0.07 |
| Cash from Financing Activity + | 3.96 | 0.96 | 7.64 | -9.16 | -12.36 |
| Net Cash Flow | 10.49 | -4.70 | -1.91 | -4.04 | 1.42 |
| Free Cash Flow | 4.59 | 3.71 | -6.85 | -0.64 | 8.74 |
| CFO/OP | 69% | 86% | 142% | 98% | 136% |
Financials of Chemcrux Enterp.
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 72.33 | 51.56 | 71.17 | 61.42 | 85.58 |
| Inventory Days | 92.33 | 124.92 | 99.63 | 135.16 | 68.51 |
| Days Payable | 92.57 | 71.19 | 70.84 | 60.56 | 104.17 |
| Cash Conversion Cycle | 72.09 | 105.28 | 99.96 | 136.01 | 49.92 |
| Working Capital Days | 37.43 | 67.28 | 55.49 | 27.94 | 87.08 |
| ROCE % | 27.63% | 13.46% | 6.69% | 7.40% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…